NETUPITANT/PALONOSETRON capsules (Akynzeo®)
Clinical Indication
Prevention of nausea and vomiting associated with chemotherapy
Comments
Not yet reviewed
Date of classification
March 2016
Grey
Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.
- New medicines, devices, appliances.
- New indication of existing medicine.
- New NICE TA which has not been reviewed.
- Not been requested for review by either TAS/LPT MMC.